US 6933279
Orally administered peptides to ameliorate atherosclerosis
expired A61KA61K38/00A61P
Quick answer
US patent 6933279 (Orally administered peptides to ameliorate atherosclerosis) held by The Regents of the University of California expires Mon Aug 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Aug 23 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 48
- CPC classes
- A61K, A61K38/00, A61P, A61P11/00, A61P17/00